{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:56:50Z","timestamp":1791413810221,"version":"4.3.3"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100013360","name":"Universidade Do Extremo Sul Catarinense","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013360","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To systematically evaluate the impact of SSRIs on sexual function in adults with depression compared to placebo through a systematic review and meta-analysis of randomized controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A systematic search using the terms\n                      <jats:italic>\u201csexual dysfunction\u201d<\/jats:italic>\n                      ,\n                      <jats:italic>\u201cdepression\u201d and \u201cantidepressant\u201d<\/jats:italic>\n                      was conducted in PubMed\/MEDLINE, LILACS, Embase, and the Cochrane Library for RCTs published up to June 2025. No language restrictions were applied. Both dichotomous and continuous outcomes were analyzed with 95% confidence intervals using RevMan 5.4. The risk of bias in individual studies was assessed independently by two reviewers using the revised Cochrane Risk of Bias tool for randomized trials (RoB 2).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen RCTs met inclusion criteria for qualitative synthesis and six were included in meta-analyses. SSRIs were significantly associated with increased risk of orgasmic dysfunction (RR\u2009=\u20093.28, (95% CI of 2.33 to 4.60,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.00001; I\u00b2 = 8%,) and reduced sexual satisfaction (RR\u2009=\u20091.21, (95% CI of 1.11 to 1.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001, I\u00b2 = 0%,). A non-significant trend toward decreased sexual desire was observed (RR\u2009=\u20091.40, 95% CI: 0.92\u20132.12,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.12; I\u00b2 = 54%,). No significant differences were detected in total CSFQ scores compared with placebo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SSRI use is consistently associated with sexual dysfunction, particularly orgasmic dysfunction and reduced sexual satisfaction. The GRADE assessment indicated high to moderate certainty of evidence. Orgasmic dysfunction showed high certainty, with concerns limited to risk of bias. Sexual satisfaction, sexual desire disorders, and CSFQ total scores demonstrated moderate certainty, mainly due to risk-of-bias issues.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00228-026-04011-z","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:31:59Z","timestamp":1771630319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sexual dysfunction associated with selective serotonin reuptake inhibitors in adults with depression: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Sarah","family":"Dagostin Ferraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Kuyunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peterson","family":"Rech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Rodrigues Uggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Claudia","family":"Rodrigues Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdemira Santina","family":"Dagostin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Rosa","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamy","family":"Colonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Jos\u00e9","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"key":"4011_CR1","unstructured":"Bains N, Abdijadid S Major Depressive Disorder. [Updated 2023 Apr 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559078\/"},{"issue":"5","key":"4011_CR2","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.3390\/ijms24054772","volume":"24","author":"L Dobrek","year":"2023","unstructured":"Dobrek L, G\u0142owacka K (2023) Depression and its phytopharmacotherap: a narrative review. Int J Mol Sci 24(5):4772. https:\/\/doi.org\/10.3390\/ijms24054772","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4011_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/amhs.amhs_102_17","volume":"6","author":"OJ Fasipe","year":"2018","unstructured":"Fasipe OJ (2018) Neuropharmacological classification of antidepressant agents based on their mechanisms of action. Arch Med Health Sci 6(1):81\u201394. https:\/\/doi.org\/10.4103\/amhs.amhs_102_17","journal-title":"Arch Med Health Sci"},{"key":"4011_CR4","first-page":"90","volume-title":"Descomplicando a psicofarmacologia","author":"E Elisabetsky","year":"2021","unstructured":"Elisabetsky E et al (2021) Descomplicando a psicofarmacologia. Editora Edgard Blucher Ltda., S\u00e3o Paulo, p 90"},{"key":"4011_CR5","unstructured":"Rush J (2023) Unipolar major depression in adults: choosing initial treatment. UpToDate, Oct 2023"},{"issue":"4","key":"4011_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.31887\/DCNS.2008.10.4\/kkelly","volume":"10","author":"K Kelly","year":"2008","unstructured":"Kelly K, Posternak M, Alpert J (2008) Toward achieving optimal response: Understanding and managing antidepressant side effects. Dialogues Clin Neurosci 10(4):409\u2013418","journal-title":"Dialogues Clin Neurosci"},{"key":"4011_CR7","volume-title":"Abordagem Da depress\u00e3o Maior Em idosos: Medidas n\u00e3o medicamentosas e medicamentosas","author":"L Wannmacher","year":"2016","unstructured":"Wannmacher L (2016) Abordagem Da depress\u00e3o Maior Em idosos: Medidas n\u00e3o medicamentosas e medicamentosas, vol 1. OPAS\/OMS \u2013 Representa\u00e7\u00e3o Brasil, Bras\u00edlia, 1"},{"key":"4011_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-clinpsy-050817-084902","volume":"14","author":"Z Cohen","year":"2018","unstructured":"Cohen Z, DeRubeis R (2018) Treatment selection in depression. Annu Rev Clin Psychol 14:209\u2013236. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050817-084902","journal-title":"Annu Rev Clin Psychol"},{"issue":"9","key":"4011_CR9","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.mayocp.2016.06.018","volume":"91","author":"T Lorenz","year":"2016","unstructured":"Lorenz T, Rullo J, Faubion S (2016) Antidepressant-induced female sexual dysfunction. Mayo Clin Proc 91(9):1280\u20131286. https:\/\/doi.org\/10.1016\/j.mayocp.2016.06.018","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"4011_CR10","doi-asserted-by":"publisher","first-page":"19875","DOI":"10.56083\/RCV3N11-003","volume":"3","author":"G Munaretto","year":"2023","unstructured":"Munaretto G et al (2023) O impacto sexual Dos antidepressivos Duais e inibidores Da recapta\u00e7\u00e3o de serotonina Em mulheres. Rev Contemp 3(11):19875\u201319895","journal-title":"Rev Contemp"},{"key":"4011_CR11","doi-asserted-by":"publisher","unstructured":"Rothmore J (2020) Antidepressant-induced sexual dysfunction. Med J Aust 212(7). https:\/\/doi.org\/10.5694\/mja2.50749","DOI":"10.5694\/mja2.50749"},{"key":"4011_CR12","doi-asserted-by":"publisher","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.\u00a0BMJ n71\u00a0https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"4011_CR13","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng HY, Corbett MS, Eldridge SM, Emberson JR, Hern\u00e1n MA, Hopewell S, Hr\u00f3bjartsson A, Junqueira DR, J\u00fcni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https:\/\/doi.org\/10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"4011_CR14","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group; Cochrane Statistical Methods Group (2011) The Cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928","journal-title":"BMJ"},{"key":"4011_CR15","doi-asserted-by":"publisher","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177-88. https:\/\/doi.org\/10.1016\/0197-2456(86)90046-2. PMID: 3802833","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"4011_CR16","unstructured":"Deeks JJ, Higgins JPT, Altman DG (2021) Analysing data and undertaking meta-analyses. Cochrane Handbook Syst Rev Intervent 6.2. https:\/\/training.cochrane.org\/handbook"},{"issue":"8","key":"4011_CR17","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1177\/1744987120927206","volume":"25","author":"S Campbell","year":"2020","unstructured":"Campbell S, Greenwood M, Prior S, Shearer T, Walkem K, Young S, Bywaters D, Walker K (2020) Purposive sampling: complex or simple? Research case examples. J Res Nurs 25(8):652\u2013661. https:\/\/doi.org\/10.1177\/1744987120927206","journal-title":"J Res Nurs"},{"issue":"4Part1","key":"4011_CR18","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1743-6109.2007.00540.x","volume":"4","author":"A Clayton","year":"2007","unstructured":"Clayton A et al (2007) Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder. J Sex Med 4(4Part1):917\u2013929. https:\/\/doi.org\/10.1111\/j.1743-6109.2007.00540.x","journal-title":"J Sex Med"},{"issue":"7","key":"4011_CR19","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S0149-2918(01)80127-6","volume":"23","author":"CC Coleman","year":"2001","unstructured":"Coleman CC et al (2001) A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and Fluoxetine. Clin Ther 23(7):1040\u20131058. https:\/\/doi.org\/10.1016\/S0149-2918(01)80127-6","journal-title":"Clin Ther"},{"issue":"4","key":"4011_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/10401239909147072","volume":"11","author":"CC Coleman","year":"1999","unstructured":"Coleman CC et al (1999) Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and Sertraline treatment. Ann Clin Psychiatry 11(4):205\u2013215","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"4011_CR21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0149-2918(99)80019-5","volume":"21","author":"H Croft","year":"1999","unstructured":"Croft H et al (1999) A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and Sertraline. Clin Ther 21(4):643\u2013658. https:\/\/doi.org\/10.1016\/S0149-2918(99)80019-5","journal-title":"Clin Ther"},{"issue":"11","key":"4011_CR22","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.4088\/JCP.14m09155","volume":"75","author":"HA Croft","year":"2014","unstructured":"Croft HA et al (2014) Efficacy and safety of Vilazodone in major depressive disorder: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 75(11):6228. https:\/\/doi.org\/10.4088\/JCP.14m09155","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"4011_CR23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1037\/0022-006X.74.4.658","volume":"74","author":"S Dimidjian","year":"2006","unstructured":"Dimidjian S et al (2006) Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol 74(4):658\u2013670. https:\/\/doi.org\/10.1037\/0022-006X.74.4.658","journal-title":"J Consult Clin Psychol"},{"key":"4011_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/10401239809147030","volume":"10","author":"M Fava","year":"1998","unstructured":"Fava M et al (1998) A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry 10:145\u2013150","journal-title":"Ann Clin Psychiatry"},{"issue":"4","key":"4011_CR25","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.4088\/JCP.10m06743","volume":"72","author":"A Khan","year":"2011","unstructured":"Khan A et al (2011) A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder. J Clin Psychiatry 72(4):16795. https:\/\/doi.org\/10.4088\/JCP.10m06743","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"4011_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/009262301750432309","volume":"27","author":"M Michelson","year":"2001","unstructured":"Michelson M, Schmidt JL, Tepner R (2001) Changes in sexual function during acute and six-month Fluoxetine therapy: a prospective assessment. J Sex Marital Ther 27(3):289\u2013302. https:\/\/doi.org\/10.1080\/009262301750432309","journal-title":"J Sex Marital Ther"},{"issue":"2","key":"4011_CR27","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1185\/030079906X164162","volume":"23","author":"AA Nierenberg","year":"2007","unstructured":"Nierenberg AA et al (2007) Duloxetine versus Escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Curr Med Res Opin 23(2):401\u2013416. https:\/\/doi.org\/10.1185\/030079906X164162","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"4011_CR28","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.eurpsy.2006.03.005","volume":"21","author":"DGS Perahia","year":"2006","unstructured":"Perahia DGS et al (2006) Duloxetine in the treatment of major depressive disorder: a placebo-and paroxetine-controlled trial. Eur Psychiatry 21(6):367\u2013378. https:\/\/doi.org\/10.1016\/j.eurpsy.2006.03.005","journal-title":"Eur Psychiatry"},{"issue":"6","key":"4011_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1185\/030079907X191289","volume":"23","author":"TA Pigott","year":"2007","unstructured":"Pigott TA et al (2007) Duloxetine versus Escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Curr Med Res Opin 23(6):1303\u20131318. https:\/\/doi.org\/10.1185\/030079907X191289","journal-title":"Curr Med Res Opin"},{"key":"4011_CR30","first-page":"18","volume":"51","author":"FW Reimherr","year":"1990","unstructured":"Reimherr FW et al (1990) Antidepressant efficacy of sertraline: a double-blind, placebo-and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51:18\u201327","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"4011_CR31","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/YCO.0000000000000192","volume":"28","author":"AL Montejo","year":"2015","unstructured":"Montejo AL, Montejo L, Navarro-Cremades F (2015) Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry 28(6):418\u2013423. https:\/\/doi.org\/10.1097\/YCO.0000000000000192","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"4011_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/JCP.0b013e3181a3928b","volume":"29","author":"A Serretti","year":"2009","unstructured":"Serretti A, Chiesa A (2009) Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 29(3):259\u2013266. https:\/\/doi.org\/10.1097\/JCP.0b013e3181a3928b","journal-title":"J Clin Psychopharmacol"},{"issue":"10","key":"4011_CR33","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1517\/14740338.2014.947043","volume":"13","author":"AH Clayton","year":"2014","unstructured":"Clayton AH, El Haddad S, Iluonakhamhe JP (2014) Sexual dysfunction associated with major depressive disorder and antidepressant treatment. Expert Opin Drug Saf 13(10):1361\u20131374. https:\/\/doi.org\/10.1517\/14740338.2014.947043","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"4011_CR34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.physbeh.2004.08.025","volume":"83","author":"EM Hull","year":"2004","unstructured":"Hull EM, Muschamp JW, Sato S (2004) Dopamine and serotonin: influences on male sexual behavior. Physiol Behav 83(2):291\u2013307. https:\/\/doi.org\/10.1016\/j.physbeh.2004.08.025","journal-title":"Physiol Behav"},{"issue":"1","key":"4011_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jad.2005.12.015","volume":"91","author":"AH Clayton","year":"2006","unstructured":"Clayton AH, Keller A, McGarvey EL (2006) Burden of Phase-Specific sexual dysfunction with SSRIs. J Affect Disord 91(1):27\u201332. https:\/\/doi.org\/10.1016\/j.jad.2005.12.015","journal-title":"J Affect Disord"},{"issue":"1","key":"4011_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.289.1.56","volume":"289","author":"HG Nurnberg","year":"2003","unstructured":"Nurnberg HG et al (2003) Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA 289(1):56\u201364. https:\/\/doi.org\/10.1001\/jama.289.1.56","journal-title":"JAMA"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04011-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:35:12Z","timestamp":1781634912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["4011"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04011-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"6 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Missing 2nd affiliation of the 2nd author.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}